Daxor has received approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656. The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body. Albumin is the major carrier molecule in the human body for […]
NEW YORK, NY–(Marketwired – Aug 28, 2015) – Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, will be filing a Form N-CSR on Monday, August 31st, disclosing its schedule of portfolio holdings as of June 30, 2015. Copies of the form will be mailed to the Company’s shareholders and will be available […]
Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations announced an update on its stock buyback program today. The Board of Directors of Daxor Corporation has given management the authority to repurchase up to 250,000 shares of its common stock in 2015. From January 1, 2015 through August 12, 2015, […]
The BVA-100 is the first FDA Approved machine to accurately measure blood volume in as little as 30 minutes. Review our product literature to learn more.